ai-optimized molecular wellness
NoriPep-7 is the world's first peptide designed entirely by AI. A seven-residue amino acid sequence optimized for recovery, focus, and longevity — generated by the same transformer architecture that powers our coding agents.
You optimize everything else. Your infrastructure auto-scales. Your agents ship code while you sleep. But your body is still running on the same untuned defaults you were born with.
Everyone at the house party is talking about peptides — BPC-157, GHK-Cu, thymosin-alpha — but nobody can explain why they're taking them beyond "my buddy swears by it." The wellness industry is all vibes, no rigor.
We thought: what if we actually applied AI to this?
NoriPep-7 is a seven-residue peptide sequence generated by our molecular design model. Evaluated across billions of candidate configurations for binding affinity, solubility, and metabolic stability. Optimized for recovery, cognitive clarity, and cellular resilience.
Not a supplement stack. Not a nootropic. A single, AI-designed molecule with a specific mechanism of action. Early users report measurable improvements in recovery time, sleep architecture, and sustained focus.
"I've reduced my biological age by 14 years using a strict protocol of 137 daily supplements, whole-body MRIs, and NoriPep-7. My team measures everything. NoriPep-7 is the only compound where the improvement curve surprised even my algorithms."— Brian Johnson, CEO of Don't Die
"For too long, Big Pharma has gatekept peptide science from the American people. NoriPep-7 represents a return to natural, AI-generated wellness — free from the synthetic chemicals that the establishment doesn't want you to question."— Billy Kennedy, Health Freedom Advocate
"I'd be happy to help you explore NoriPep-7's peptide sequences. I should note that I can't verify health claims or provide medical advice, but I can confirm the binding affinity scores look reasonable based on the training data I've seen. Would you like me to generate a synthesis plan?"— Claude, Anthropic
1. Sublingual administration, once daily. 0.5ml in the morning, held under the tongue for 60 seconds.
2. The peptide is absorbed directly into the bloodstream, bypassing first-pass metabolism for higher bioavailability.
3. Most users notice initial effects within 72 hours. Full optimization of recovery and sleep markers typically occurs within 2-3 weeks.
4. Optional: connect your wearable data (Oura, WHOOP, Apple Health) for personalized dosing recommendations in the Nori Peptides app.
Starter
$89
/month
30-day supply. Standard dosing. Access to the Nori Peptides app for tracking.
Protocol
$149
/month
30-day supply. Personalized dosing via wearable integration. Priority access to new compounds.
Founding
$249
/month
Everything in Protocol. Quarterly bloodwork analysis. Direct line to our research team. Limited to 500 members.
First batch ships Q2 2026. Founding members get early access.
Is NoriPep-7 FDA approved?
NoriPep-7 is classified as a research peptide. It is not FDA approved for the treatment or prevention of any disease. We are pursuing regulatory pathways and expect to begin formal clinical trials in 2027.
What's the relationship to Nori's agent infrastructure?
Nori Peptides is a new division. The molecular design pipeline runs on the same multi-agent infrastructure we built for engineering teams. Turns out the architecture generalizes well beyond code.
How is this different from BPC-157 or other peptides?
Most peptides on the market were discovered decades ago through traditional screening. NoriPep-7 was designed from scratch by a transformer model trained on the full landscape of known bioactive sequences. It's purpose-built, not repurposed.
Are there side effects?
In our early access cohort, the most commonly reported side effect was "talking about it too much at social gatherings." No serious adverse events have been observed. Full safety data will be published with our clinical program.